Florida's 2023 Lawsuit Reforms Drive Insurance Market Stability
Florida's 2023 lawsuit reform package reduces litigation costs, lowers insurance premiums, and attracts new insurers, stabilizing the state's auto and homeowners insurance markets.
Florida's 2023 lawsuit reform package reduces litigation costs, lowers insurance premiums, and attracts new insurers, stabilizing the state's auto and homeowners insurance markets.
NASCAR's Kyle Busch lost $8.6 million in premiums due to fees and performance issues in an Indexed Universal Life insurance policy sold by Pacific Life. This case highlights risks and compliance issues in IUL policies for insurance professionals.
Triple-I and CAS study reveals liability insurance deficits between $231.6B and $281.2B over 2015-2024 due to rising claims costs and legal system factors, exceeding standard inflation.
USDA discontinues Household Food Security Report as federal nutrition assistance programs face cuts and new Medicaid work requirements loom, complicating tracking of hunger trends.
Sentara Health Plans will discontinue several Medicare Advantage products in Virginia, North Carolina, and Florida by end of 2025 due to financial and regulatory challenges, affecting member coverage options during Medicare open enrollment.
Blue Cross Blue Shield to discontinue Vermont Medicare Advantage plans next year after substantial financial losses, impacting 30,000 Vermonters and requiring plan changes.
Explore how a 32% rise in plaintiff attorney advertising in 2024 is influencing U.S. property and casualty insurance costs, with insights from expert Robert P. Hartwig.
Hawaii's Insurance Division highlights the NAIC's Life Insurance Policy Locator tool helping recover unclaimed life insurance benefits and annuities in 2025.
The looming deadline for drugmakers to comply with the Most Favored Nation drug pricing policy raises concerns over potential disruptions to Medicare Part D, highlighting regulatory and market risks for U.S. drug pricing and federal entitlement programs.
Humana's stock sees an 18% decline over 12 months despite 7% revenue and 21% net income growth. Regulatory and operational challenges may impact future earnings.